Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECUT: Reduced Corticosteroid Duration in COPD Exacerbation
NCT02386735Terminated
- Start
- Mar 2015
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of prednisone in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: Time to next exacerbation at 6 months. Started Mar 2015; status: terminated.
02
Drugs
prednisone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02386735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02386735.